BIOMAT Database Logo BIOMAT Database Logo

Correction to: Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations. 2021

Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
PharmaInformatics Unit, Research Center ATHENA, Athens, Greece.

UI MeSH Term Description Entries

Related Publications

Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Correction to: Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts.
September 2020, Pharmaceutical research,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts.
September 2020, Pharmaceutical research,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
March 2017, The AAPS journal,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Pharmacokinetics of rifampin in children. II. Oral bioavailability.
January 1986, Therapeutic drug monitoring,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Bioavailability and Bioequivalence in Drug Development.
January 2014, Wiley interdisciplinary reviews. Computational statistics,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
January 1978, American journal of pharmacy and the sciences supporting public health,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Evaluation and prediction of oral drug absorption and bioequivalence with food-druginteraction.
June 2023, Drug metabolism and pharmacokinetics,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Drug absorption and bioavailability.
August 1978, The Medical journal of Australia,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies.
December 1996, Clinical pharmacology and therapeutics,
Pavlos Chryssafidis, and Athanasios A Tsekouras, and Panos Macheras
Predicting oral absorption and bioavailability.
January 2003, Progress in medicinal chemistry,
Copied contents to your clipboard!